Mutual of America Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Mutual of America Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Buy	+41,504	New	+$2.15M	0.03%	695

Other funds holding KNSA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mutual of America Capital Management's KNSA Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 41,504 shares worth $2.65M. The stake represents 0.03% of the portfolio and ranks #695 among its holdings.

123 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Mutual of America Capital Management held 41,504 shares of Kiniksa Pharmaceuticals worth $2.65M as of Q2 2026.
Kiniksa Pharmaceuticals was a new Mutual of America Capital Management position in Q2 2026.
Kiniksa Pharmaceuticals made up 0.03% of Mutual of America Capital Management's portfolio in Q2 2026, its #695 holding.
123 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.